In support of this hypothesis, we observed an inverse correlation of Brg1 and E-cadherin expression, a tumor suppressive protein that has been reported to be suppressed by Brg112,24, in gastric cancer clinical samples (Fig. 3g, i). This evidence concerns the gene SMARCA4 and gastric cancer.